A randomized, double-blind, multicenter, parallel group study to compare relative efficacies of the topical gels 3% erythromycin/5% benzoyl peroxide and 0.025% tretinoin/erythromycin 4% in the treatment of moderate acne vulgaris of the face

Journal of Cutaneous Medicine and Surgery

Volumn 7, Issue 1, 2003, Pages 31-37

  Gupta, Aditya K ^a,b,d   Lynde, Charles W ^c   Kunynetz, Rod A W ^c   Amin, Smita ^c   Choi, Ken Lee ^c   Goldstein, Eric ^c  

^a UNIVERSITY OF TORONTO   (Canada)

^b Mediprobe Laboratories Inc   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BENZAMYCIN; CLINESFAR; ERYTHROMYCIN; RETINOIC ACID; STIEVAMYCIN; UNCLASSIFIED DRUG;

ACNE VULGARIS; ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DESQUAMATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MIXTURE; DRY SKIN; ERYTHEMA; FACE DISORDER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARALLEL DESIGN; PATIENT SATISFACTION; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SKIN BURNING SENSATION; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ACNE VULGARIS; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; BENZOYL PEROXIDE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ERYTHROMYCIN; FACE; GELS; HUMANS; KERATOLYTIC AGENTS; TREATMENT OUTCOME; TRETINOIN;

EID: 0037231503     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10227-002-2101-2     Document Type: Article

References (10)

1. Leyden J. Introduction. Cutis 2001; 67:5-7.
2. Leyden JJ, Hickman JG, Jarratt MT, et al. The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product. J Cutan Med Surg 2001; 5(1):37-42.
3. Webster G. Combination azelaic acid therapy for acne vulgaris. J Am Acad Dermatol 2000; 43(2 Pts):S47-S50.
4. Eady EA, Bojar RA, Jones CE, et al. The effects of acne treatment with a combination of benzoyl peroxide and erythromycin on skin carriage of erythromycin-resistant propionibacteria. Br J Dermatol 1996; 134(1):107-113.
5. Leyden J, Levy S. The development of antibiotic resistance in propionibacterium acnes. Cutis 2001; 67:21-24.
6. Lookingbill DP, Chalker DK, Lindholm JS, et al. Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations. J Am Acad Dermatol 37(4):590-595.
7. Chu A, Huber FJ, Plott RT. The comparative efficacy of benzoyl peroxide 5%/erythromycin 3% gel and erythromycin 4%/zinc 1.2% solution in the treatment of acne vulgaris. Br J Dermatol 1997; 136(2):235-238.
8. Ellis CN, Leyden JJ, Katz HI, et al. Therapeutic studies with a new combination benzoyl peroxide/clindamycin topical gel in acne vulgaris. Cutis 2001; 67:13-20.
9. Burke B, Eady EA, Cunliffe WJ. Benzoyl peroxide versus topical erythromycin in the treatment of acne vulgaris. Br J Dermatol 1983; 108(2):199-204.
10. Chalker DK, Shalita A, Smith Jr JG, et al. A double-blind study of the effectiveness of a 3% erythromycin and 5% benzoyl peroxide combination in the treatment of acne vulgaris. J Am Acad Dermatol 1983; 9(6):933-936.